Keya Medical Closes ￥150M Series B+ Round

According to VCBeat, Keya Medical has closed ￥150 million in a Series B+ funding round led by GGV Capital while prior backers Kunlun, Shanghai International Group ("SIG") and Yahui Capital took part as well.

Proceeds from the latest round will be mainly used to complete the commercialization of products Keya Medical globally, and provide an important driving force for the subsequent brand upgrade, product R&D and market expansion.

As early as February this year, Keya Medical has obtained 100 million yuan in a round led by Kunlun and IDG Capital, with participation from SIG, Yahui Capital and others.

Keya Medical is an international medical AI R&D company developing software medical devices and providing professional services to medical technology vendors, healthcare organizations, and pharmaceutical companies. Our machine learning scientists, software engineers, and designers collaborate with leading medical centers around the world to apply the latest advances in machine learning, medical informatics, and regulatory science to improve human health.

As a company specializing in AI-based cardiovascular products, Keya Medical mainly develops precise diagnosis products and AI medical imaging solution of coronary artery disease (CAD), focusing on the application of PAAS layer. Among them, the calculation software of coronary flow reserve (CFR) independently developed by Keya Medical has obtained the approval of the Center for Medical Device Evaluation (MDE) of China, which makes it the first third-class AI-powered medical device approved in China, and is the only domestic product with certificated by NMPA and EU. 

The software not only helps doctors to get real and effective clinical data, but also optimizes doctors' diagnosis and treatment plan while avoiding excessive treatment of patients, thus reducing patients' economic burden and social medical cost.

Founded in 2000, GGV Capital is a global venture capital firm that invests in local founders. As a multi-stage, sector-focused firm, GGV focuses on seed-to-growth stage investments across Consumer/New Retail, Social/Digital & Internet, Enterprise/Cloud and Frontier Tech sectors. 

Kunlun is an Internet group that is dedicated to the development of interactive platforms and applications for global user groups. Around the "AI+" field, Kunlun has invested in Pony AI, Innoviz, Krazybee, and other AI technology companies in the past two years.